Somatrogon-ghla
Orphan Drug Cold Chain RequiredFDA Approved
Description
Somatrogon-ghla is a recombinant human growth hormone indicated for pediatric patients. It is used for the treatment of growth hormone deficiency.
Indications & Therapeutic Use
Growth hormone deficiency
Linked Diseases:
Stimmler syndrome
C565968
Global Availability (2 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — |
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Somatrogon-ghla
| Generic Name | Somatrogon-ghla |
| Brands | 1 brand available |
| Active Ingredient | Somatrogon-ghla |
| Drug Class | Growth hormone deficiency |
| Manufacturer | Pfizer |
| Dosage Forms | Injection |
| Medical Code | H01AC07 |
| Orphan Status | Yes — Orphan Drug |
| Cold Chain | Required |
| Reg. Status | FDA Approved |
| Clinical Trial | NCT02963098 |
| Countries | 2 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations3 Validated Nodes